Payment overview · 2025
General Payments
$117.19
4 reported records · 2 companies
Healthcare provider profile · identity verified
Anh Nguyen
Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant|Medical · ROCHESTER, NY · NPI 1124477633
Verified facts
What the public records show
CMS Open Payments records show Anh Nguyen received $117.19 in general payments during 2025 across 4 reported records.
Octapharma USA, Inc. accounted for 57.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Octapharma USA, Inc. | Unresolved — no canonical attribution shown | $66.80 | 57.0% | 3 | 2025 |
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $50.39 | 43.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $117.19 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FIBRYGA Normalized: fibryga |
Biological | Octapharma USA, Inc. | $66.80 | 3 | 2025 |
Source payment records
|
|||||
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $50.39 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 991 | 496 |
| Amlodipine Besylate | Amlodipine Besylate | 662 | 331 |
| Levothyroxine Sodium | Levothyroxine Sodium | 587 | 277 |
| Lisinopril | Lisinopril | 498 | 260 |
| Losartan Potassium | Losartan Potassium | 395 | 204 |
| Hydrochlorothiazide | Hydrochlorothiazide | 370 | 187 |
| Omeprazole | Omeprazole | 360 | 175 |
| Metoprolol Succinate | Metoprolol Succinate | 330 | 164 |
| Gabapentin | Gabapentin | 327 | 131 |
| Simvastatin | Simvastatin | 302 | 133 |
| Metformin Hcl | Metformin Hcl | 240 | 120 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 227 | 106 |
| Pantoprazole Sodium | Pantoprazole Sodium | 218 | 110 |
| Metformin Hcl Er | Metformin Hcl | 193 | 102 |
| Fluticasone Propionate | Fluticasone Propionate | 191 | 86 |
| Sertraline Hcl | Sertraline Hcl | 188 | 96 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 183 | 108 |
| Trazodone Hcl | Trazodone Hcl | 178 | 71 |
| Eliquis | Apixaban | 158 | 57 |
| Famotidine | Famotidine | 149 | 74 |
| Allopurinol | Allopurinol | 142 | 73 |
| Furosemide | Furosemide | 141 | 69 |
| Metoprolol Tartrate | Metoprolol Tartrate | 121 | 56 |
| Duloxetine Hcl | Duloxetine Hcl | 120 | 58 |
| Montelukast Sodium | Montelukast Sodium | 116 | 53 |
| Fluoxetine Hcl | Fluoxetine Hcl | 114 | 47 |
| Atenolol | Atenolol | 113 | 56 |
| Carvedilol | Carvedilol | 108 | 45 |
| Potassium Chloride | Potassium Chloride | 108 | 50 |
| Tamsulosin Hcl | Tamsulosin Hcl | 102 | 57 |
| Pravastatin Sodium | Pravastatin Sodium | 100 | 57 |
| Warfarin Sodium | Warfarin Sodium | 99 | 41 |
| Meloxicam | Meloxicam | 97 | 46 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 94 | 47 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 93 | 36 |
| Alendronate Sodium | Alendronate Sodium | 86 | 44 |
| Citalopram Hbr | Citalopram Hydrobromide | 86 | 39 |
| Torsemide | Torsemide | 83 | 32 |
| Doxycycline Hyclate | Doxycycline Hyclate | 81 | 76 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 79 | 27 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 78 | 36 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 76 | 41 |
| Buspirone Hcl | Buspirone Hcl | 73 | 36 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 73 | 34 |
| Bupropion Xl | Bupropion Hcl | 72 | 39 |
| Glipizide | Glipizide | 72 | 38 |
| Chlorthalidone | Chlorthalidone | 68 | 27 |
| Ezetimibe | Ezetimibe | 67 | 29 |
| Lovastatin | Lovastatin | 67 | 32 |
| Escitalopram Oxalate | Escitalopram Oxalate | 65 | 32 |
| Ozempic | Semaglutide | 62 | 34 |
| Clopidogrel | Clopidogrel Bisulfate | 61 | 26 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 52 | 20 |
| Spironolactone | Spironolactone | 52 | 26 |
| Terazosin Hcl | Terazosin Hcl | 51 | 17 |
| Irbesartan | Irbesartan | 50 | 29 |
| Prednisone | Prednisone | 49 | 44 |
| Trulicity | Dulaglutide | 49 | 16 |
| Mirtazapine | Mirtazapine | 48 | 18 |
| Valsartan | Valsartan | 46 | 27 |
| Cephalexin | Cephalexin | 44 | 40 |
| Jardiance | Empagliflozin | 44 | 18 |
| Paroxetine Hcl | Paroxetine Hcl | 44 | 24 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 44 | 12 |
| Enalapril Maleate | Enalapril Maleate | 43 | 18 |
| Hydralazine Hcl | Hydralazine Hcl | 42 | 15 |
| Januvia | Sitagliptin Phosphate | 40 | 20 |
| Ibuprofen | Ibuprofen | 39 | 21 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 39 | 22 |
| Xarelto | Rivaroxaban | 38 | 11 |
| Amitriptyline Hcl | Amitriptyline Hcl | 37 | 16 |
| Glipizide Er | Glipizide | 37 | 21 |
| Glimepiride | Glimepiride | 36 | 21 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 36 | 20 |
| Alprazolam | Alprazolam | 34 | 29 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 34 | 15 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 34 | 27 |
| Tramadol Hcl | Tramadol Hcl | 34 | 24 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 33 | 33 |
| Finasteride | Finasteride | 33 | 16 |
| Nifedipine Er | Nifedipine | 33 | 12 |
| Naproxen | Naproxen | 32 | 19 |
| Zolpidem Tartrate | Zolpidem Tartrate | 32 | 22 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 31 | 14 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 31 | 24 |
| Meclizine Hcl | Meclizine Hcl | 30 | 14 |
| Nortriptyline Hcl | Nortriptyline Hcl | 30 | 11 |
| Ropinirole Hcl | Ropinirole Hcl | 30 | 16 |
| Synthroid | Levothyroxine Sodium | 30 | 17 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 30 | 13 |
| Celecoxib | Celecoxib | 29 | 16 |
| Diclofenac Sodium | Diclofenac Sodium | 29 | 15 |
| Pioglitazone Hcl | Pioglitazone Hcl | 29 | 15 |
| Bupropion Hcl Sr | Bupropion Hcl | 28 | 12 |
| Labetalol Hcl | Labetalol Hcl | 28 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 28 | 13 |
| Baclofen | Baclofen | 27 | 11 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 27 | 13 |
| Sumatriptan Succinate | Sumatriptan Succinate | 27 | 11 |
| Lorazepam | Lorazepam | 25 | 20 |
| Ondansetron Hcl | Ondansetron Hcl | 25 | 16 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 25 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 24 | suppressed |
| Lansoprazole | Lansoprazole | 24 | 13 |
| Azithromycin | Azithromycin | 23 | 19 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 23 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 22 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 21 | 18 |
| Clonazepam | Clonazepam | 21 | 16 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 21 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 21 | suppressed |
| Verapamil Er | Verapamil Hcl | 21 | suppressed |
| Amoxicillin | Amoxicillin | 20 | 19 |
| Tizanidine Hcl | Tizanidine Hcl | 20 | 11 |
| Fenofibrate | Fenofibrate Nanocrystallized | 19 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 19 | suppressed |
| Levetiracetam | Levetiracetam | 19 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 18 | 14 |
| Lamotrigine | Lamotrigine | 18 | suppressed |
| Pregabalin | Pregabalin | 18 | 11 |
| Propranolol Hcl Er | Propranolol Hcl | 18 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 18 | 11 |
| Valacyclovir | Valacyclovir Hcl | 17 | 14 |
| Fluconazole | Fluconazole | 16 | 12 |
| Rybelsus | Semaglutide | 16 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 15 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 15 | suppressed |
| Lidocaine | Lidocaine | 15 | suppressed |
| Methylprednisolone | Methylprednisolone | 15 | 15 |
| Nabumetone | Nabumetone | 15 | suppressed |
| Naloxone Hcl | Naloxone Hcl | 15 | 15 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 14 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 14 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 14 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 14 | suppressed |
| Fenofibrate | Fenofibrate | 14 | suppressed |
| Nystatin | Nystatin | 14 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 14 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 14 | suppressed |
| Ramipril | Ramipril | 14 | suppressed |
| Acyclovir | Acyclovir | 13 | suppressed |
| Klor-Con M20 | Potassium Chloride | 13 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 13 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 13 | suppressed |
| Topiramate | Topiramate | 13 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 12 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 12 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 12 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 12 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Ondansetron Odt | Ondansetron | 12 | suppressed |
| Epinephrine | Epinephrine | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $117.19 · 4 records | Octapharma USA, Inc. | Dexcom G6 Transmitter, FIBRYGA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error